Risk of Infective Endocarditis Post-transcatheter Pulmonary Valve Replacement Versus Surgical Pulmonary Valve Replacement: A Systematic Review.
infective endocarditis
percutaneous pulmonary valve implantation
percutaneous pulmonary valve replacement
pulmonary valve replacement
surgical valve replacement
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
accepted:
29
10
2023
medline:
30
11
2023
pubmed:
30
11
2023
entrez:
30
11
2023
Statut:
epublish
Résumé
Pulmonary valve replacement (PVR) is the most common cardiac operation in adult patients with congenital heart disease (ACHD). It can improve right ventricular outflow tract (RVOT) obstruction, typically due to pulmonary valve stenosis or regurgitation. PVR can be performed surgically (open-heart) and through a transcatheter (percutaneous) method, which is minimally invasive and is associated with shorter hospitalization stays. However, following PVR, infectious endocarditis (IE) can complicate the recovery process and increase mortality in the long term. IE is a rare but deadly multi-organ system condition caused by microorganisms traversing the bloodstream from a specific entry point. It can have many presentations, such as splinter hemorrhages, fevers, and vegetation on valves that lead to stroke consequences. This paper aims to evaluate the differences in the rate, etiology, manifestations, treatment, and outcomes of IE following surgical and transcatheter PVR, as the goal is to perform a procedure with few complications. In both approaches,
Identifiants
pubmed: 38034152
doi: 10.7759/cureus.48022
pmc: PMC10687661
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e48022Informations de copyright
Copyright © 2023, Slouha et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Int J Cardiol. 2021 Jan 15;323:40-46
pubmed: 32860844
Int J Cardiol. 2018 Aug 15;265:47-51
pubmed: 29724567
Heart. 2015 May 15;101(10):788-93
pubmed: 25539944
Turk Gogus Kalp Damar Cerrahisi Derg. 2022 Jul 29;30(3):472-483
pubmed: 36303703
Cardiol J. 2021;28(4):566-578
pubmed: 34031866
Arch Cardiovasc Dis. 2018 Aug - Sep;111(8-9):497-506
pubmed: 29530718
J Am Heart Assoc. 2022 Mar;11(5):e022231
pubmed: 35179045
Arch Cardiovasc Dis. 2015 Feb;108(2):97-106
pubmed: 25445752
J Thorac Cardiovasc Surg. 2018 Aug;156(2):728-734.e2
pubmed: 29753513
Heart. 2002 Jul;88(1):61-6
pubmed: 12067947
Catheter Cardiovasc Interv. 2018 Feb 1;91(2):277-284
pubmed: 28895275
J Thorac Dis. 2019 Dec;11(12):5343-5351
pubmed: 32030252
J Thorac Cardiovasc Surg. 2014 Nov;148(5):2253-9
pubmed: 25218536
Heart Lung Circ. 2020 Dec;29(12):1799-1807
pubmed: 32616369
Methodist Debakey Cardiovasc J. 2019 Apr-Jun;15(2):122-132
pubmed: 31384375
J Infect Dis. 2002 Apr 1;185(7):994-7
pubmed: 11920326
BMJ. 2009 Jul 21;339:b2700
pubmed: 19622552
JACC Cardiovasc Interv. 2017 Mar 13;10(5):510-517
pubmed: 28279319
Cardiol Ther. 2012 Dec;1(1):5
pubmed: 25135159
Nat Rev Dis Primers. 2016 Sep 01;2:16059
pubmed: 27582414
Circ Cardiovasc Interv. 2013 Jun;6(3):292-300
pubmed: 23735475
J Cardiol. 2019 Sep;74(3):197-205
pubmed: 31113702
J Am Coll Cardiol. 2018 Dec 4;72(22):2717-2728
pubmed: 30497557
Cardiol Young. 2017 Mar;27(2):294-301
pubmed: 27161361
J Clin Med. 2021 Feb 13;10(4):
pubmed: 33668597
Eur J Cardiothorac Surg. 2019 Jul 1;56(1):87-93
pubmed: 30698682